Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Barbara Streckenbach"'
Autor:
Janina Meißner, Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, Pegah Mashhadiakbar, Barbara Streckenbach, Katja Burian, Julia Baldt, Felicita Heidler, Jörg Richter, Uwe Klaus Zettl
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Background: The modifiable risk factor exerting the most substantial influence on the development and disease course of multiple sclerosis (MS) is cigarette smoking. Furthermore, smoking is associated with a higher risk of suffering from one or more
Externí odkaz:
https://doaj.org/article/3ddc7082b198487295d9ac6ebf8978d5
Autor:
Katja Burian, Felicita Heidler, Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, Pegah Mashhadiakbar, Barbara Streckenbach, Julia Baldt, Janina Meißner, Jörg Richter, Uwe Klaus Zettl
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract The recent SARS-CoV-2 pandemic and the vaccination campaign posed a challenge to patients with autoimmune disease, such as multiple sclerosis (MS). We aimed for investigating whether psychological/sociodemographic/clinical characteristics of
Externí odkaz:
https://doaj.org/article/0243244606ff4835a2f34a8992d78efe
Autor:
Felicita Heidler, Julia Baldt, Niklas Frahm, Silvan Elias Langhorst, Pegah Mashhadiakbar, Barbara Streckenbach, Katja Burian, Uwe Klaus Zettl, Jörg Richter
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Vaccination is a key strategy for controlling the SARS-CoV-2 pandemic. Acceptance of SARS-CoV-2 vaccines by chronically ill patients, such as multiple sclerosis (MS) patients, plays an important role in prevention of complicated disease cour
Externí odkaz:
https://doaj.org/article/645b8678adf148479a9816cddc500b7b
Autor:
Marie-Celine Haker, Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, Pegah Mashhadiakbar, Jane Louisa Debus, Barbara Streckenbach, Julia Baldt, Felicita Heidler, Uwe Klaus Zettl
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 14 (2023)
Background: Although effective contraception is strongly recommended during the therapy of women with multiple sclerosis (MS) with some immunomodulatory drugs, unplanned pregnancies still occur. Adequate medication management is essential to avoid fo
Externí odkaz:
https://doaj.org/article/07c34c4711ef44029636bb6a1a608feb
Autor:
Michael Hecker, Niklas Frahm, Paula Bachmann, Jane Louisa Debus, Marie-Celine Haker, Pegah Mashhadiakbar, Silvan Elias Langhorst, Julia Baldt, Barbara Streckenbach, Felicita Heidler, Uwe Klaus Zettl
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Patients with multiple sclerosis (MS) often undergo complex treatment regimens, resulting in an increased risk of polypharmacy and potential drug-drug interactions (pDDIs). Drug interaction databases are useful for identifying pDDIs to su
Externí odkaz:
https://doaj.org/article/90ce57165a814843921a55a9b6f19721
Autor:
Jane Louisa Debus, Paula Bachmann, Niklas Frahm, Pegah Mashhadiakbar, Silvan Elias Langhorst, Barbara Streckenbach, Julia Baldt, Felicita Heidler, Michael Hecker, Uwe Klaus Zettl
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Background: Multiple sclerosis (MS) is the most common immune-mediated demyelinating disease in younger adults. Patients with MS (PwMS) are vulnerable to the presence of potential drug–drug interactions (pDDIs) and potential drug–food interaction
Externí odkaz:
https://doaj.org/article/7ffed6baa81046d5b6ffffbd26dad43b
Autor:
Paula Bachmann, Niklas Frahm, Jane Louisa Debus, Pegah Mashhadiakbar, Silvan Elias Langhorst, Barbara Streckenbach, Julia Baldt, Felicita Heidler, Michael Hecker, Uwe Klaus Zettl
Publikováno v:
Pharmaceutics, Vol 14, Iss 3, p 592 (2022)
Polypharmacy (PP) is a common problem in modern medicine, especially known to affect patients with chronic diseases such as multiple sclerosis (MS). With an increasing number of drugs taken, the risk of potential drug–drug interactions (pDDIs) is r
Externí odkaz:
https://doaj.org/article/9b586d293e8449dfb6e63d1e7845f9f6
Autor:
Barbara, Streckenbach, Julia, Baldt, Felicita, Heidler, Niklas, Frahm, Silvan Elias, Langhorst, Pegah, Mashhadiakbar, Katja, Burian, Uwe Klaus, Zettl, Jörg, Richter
Publikováno v:
Vaccine. 40:3236-3243
Infections can have a significant impact on morbidity and mortality in multiple sclerosis (MS) patients. Therefore, vaccinations are of immense importance. If vaccination willingness is to be increased, possible influencing factors should be identifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97575b75d017c7ec814228799c106331
https://doi.org/10.1016/j.vaccine.2022.04.012
https://doi.org/10.1016/j.vaccine.2022.04.012
Autor:
Uwe K. Zettl, Silvan Elias Langhorst, Pegah Mashhadiakbar, Barbara Streckenbach, Felicita Heidler, Jörg Richter, Julia Baldt, Niklas Frahm
Publikováno v:
European Neurology. 85:104-111
Background: Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection represents a serious health risk, especially in chronically ill people. Multiple sclerosis (MS) is the most common chronic immune-mediated neurological disease. V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd0b84ee7d0be2cd69dbd60c516e60dd
https://doi.org/10.1159/000519582
https://doi.org/10.1159/000519582
Autor:
Silvan Elias Langhorst, Niklas Frahm, Michael Hecker, Pegah Mashhadiakbar, Barbara Streckenbach, Julia Baldt, Felicita Heidler, Uwe Klaus Zettl
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 5; Pages: 677
Multiple sclerosis (MS) is a chronic immune-mediated disease with a neurodegenerative component of the central nervous system. Immunomodulatory therapy can increase the risk of infection, which is a particular risk for MS patients. Therefore, a compl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c45a5ea9887a8e180b4e9fc5e5fc7f86
https://pubmed.ncbi.nlm.nih.gov/35629100
https://pubmed.ncbi.nlm.nih.gov/35629100